| Name | Title | Contact Details |
|---|
A-Dec, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Newberg, OR. To find more information about A-Dec, Inc., please visit www.a-dec.com
SleepImage Ring The SleepImage Rings stream data to the SleepImage Mobile App for upload, offering the highest level of comfort and convenience. SleepImage Mobile App The SleepImage Mobile App collects sleep data and automatically uploads it in the mo...
Ihs Health Group is a Englewood, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Tapinator (Ticker: TAPM) is a global developer and publisher of mobile games on the iOS, Google Play, and Amazon platforms. The Company focuses on operating its own titles, publishing properties where it holds substantial ownership positions, and making strategic investments into promising mobile companies. Tapinator’s owned and operated portfolio includes over 55 mobile gaming titles that, collectively, have over 30 million users. A number of these titles have risen to the top of the mobile leaderboard charts and have been featured by the Apple, Google, and Amazon App Stores. Founded in 2013, Tapinator is headquartered in New York, with development offices in Pakistan, Denmark and Indonesia.
Nivalis Therapeutics (formerly N30Pharma) is developing a novel class of disease modifying therapies that preserve intracellular GSNO (S-nitrosoglutathione), a key regulator of organ repair, regeneration, and healing. The Company’s lead program is focused on cystic fibrosis. As the body’s primary reservoir of nitric oxide (NO), GSNO plays a pivotal role in NO signaling. Decreased GSNO levels are associated with inflammatory lung disease, and with increased activity of GSNOR (GSNO reductase), the primary catabolizing enzyme of GSNO. Nivalis Therapeutics has developed a broad portfolio of proprietary, potent, small molecule inhibitors of GSNOR that have been shown to preserve endogenous GSNO levels and to be effective in “gold-standard” models of inflammatory lung disease. Nivalis Therapeutics is located in Boulder, Colorado.